Selenium in Prostate Cancer: Prevention, Progression, and Treatment
- PMID: 37765058
- PMCID: PMC10536940
- DOI: 10.3390/ph16091250
Selenium in Prostate Cancer: Prevention, Progression, and Treatment
Abstract
Selenium, a trace mineral with various biological functions, has become a focal point in prostate cancer research. This review aims to present a comprehensive overview of selenium's involvement in prostate cancer, covering its impact on prevention, development, treatment, and underlying mechanisms. Observational studies have revealed a link between selenium levels and selenoproteins with prostate cancer progression. However, randomized controlled studies have shown that selenium supplementation does not prevent prostate cancer (HR: 0.95; 95% CI 0.80-1.13). This discrepancy might be attributed to selenoprotein single nucleotide polymorphisms. In the context of combinatorial therapy, selenium has demonstrated promising synergistic potential in the treatment of prostate cancer. Emerging evidence highlights the significant role of selenium and selenoproteins in prostate cancer, encompassing AR signaling, antioxidative properties, cell death, cell cycle regulation, angiogenesis, epigenetic regulation, immunoregulation, epithelial-mesenchymal transformation, and redox signal. In conclusion, selenium's diverse properties make it a promising trace mineral in prostate cancer prevention, development, and treatment and as a platform for exploring novel agents.
Keywords: chemoprevention; progression; prostate cancer; selenium; selenoprotein; therapy.
Conflict of interest statement
All the authors declare no conflict of interest.
Figures
Similar articles
-
Selenium Deficiency.2023 Oct 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Oct 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489289 Free Books & Documents.
-
The diverse role of selenium within selenoproteins: a review.J Am Diet Assoc. 1999 Jul;99(7):836-43. doi: 10.1016/S0002-8223(99)00198-4. J Am Diet Assoc. 1999. PMID: 10405682 Review.
-
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.PLoS One. 2012;7(11):e48709. doi: 10.1371/journal.pone.0048709. Epub 2012 Nov 1. PLoS One. 2012. PMID: 23133653 Free PMC article.
-
Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells.Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1715-27. doi: 10.1089/ars.2005.7.1715. Antioxid Redox Signal. 2005. PMID: 16356132 Review.
-
Rethinking mercury: the role of selenium in the pathophysiology of mercury toxicity.Clin Toxicol (Phila). 2018 May;56(5):313-326. doi: 10.1080/15563650.2017.1400555. Epub 2017 Nov 10. Clin Toxicol (Phila). 2018. PMID: 29124976
Cited by
-
Beneficial Effects of Selenium and Its Supplementation on Carcinogenesis and the Use of Nanoselenium in the Treatment of Malignant Tumors.Int J Mol Sci. 2024 Oct 20;25(20):11285. doi: 10.3390/ijms252011285. Int J Mol Sci. 2024. PMID: 39457066 Free PMC article. Review.
-
Selenium, Zinc, and Plasma Total Antioxidant Status and the Risk of Colorectal Adenoma and Cancer.Metabolites. 2024 Sep 6;14(9):486. doi: 10.3390/metabo14090486. Metabolites. 2024. PMID: 39330493 Free PMC article.
References
-
- Ornish D., Weidner G., Fair W.R., Marlin R., Pettengill E.B., Raisin C.J., Dunn-Emke S., Crutchfield L., Jacobs F.N., Barnard R.J., et al. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 2005;174:1065–1069; discussion 1069–1070. doi: 10.1097/01.ju.0000169487.49018.73. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials